RESUMEN
Clinical evidence suggests that early endothelial cell (EC) dysfunction may predict the development of graft vascular disease. We wished to assess the early functional and morphological changes in the graft endothelium in a commonly used animal model of graft vascular disease, the rat aortic interposition allograft model. To assess graft EC function, regulation of vascular tone by ECs was monitored in aortic rings from grafts harvested at various times after transplantation (Tx). EC morphology was assessed by silver staining, which was followed by en face inspection of the luminal side of the grafts. Acetylcholine-induced EC-dependent vasorelaxation was reduced in allografts at post-Tx days 7 and 14, whereas in syngeneic grafts EC-dependent relaxation was unaffected at any time after Tx. In separate grafts collected at the same time points, massive leukocyte adhesion at post-Tx day 7 and EC denudation at days 14 and 28 were evident in allografts but not in syngeneic grafts. At post-Tx day 56 (a time at which vessel wall remodeling is pronounced in this model), an intact EC layer covered the grafts. EC dysfunction and morphological changes were prevented by immunosuppression of recipient rats with cyclosporine. Our study shows that Tx-induced EC dysfunction in rat aortic allografts can be observed within 1 week of Tx in rat aortic allografts and that this is occurring concomitantly with enhanced leukocyte adhesion to the graft ECs. These changes occur before any other morphological or functional changes described thus far in this model and appear to be immune-driven. Taken together, these results show that Tx-induced early EC dysfunction, as described in patients, may be studied in the model of rat aortic Tx.
Asunto(s)
Aorta/fisiopatología , Aorta/trasplante , Endotelio Vascular/patología , Endotelio Vascular/fisiopatología , Animales , Aorta/patología , Enfermedad Injerto contra Huésped/patología , Enfermedad Injerto contra Huésped/fisiopatología , Técnicas In Vitro , Relajación Muscular , Músculo Liso Vascular/patología , Músculo Liso Vascular/fisiopatología , Ratas , Ratas Endogámicas Dahl , Ratas Endogámicas Lew , Tinción con Nitrato de Plata , Trasplante Homólogo/efectos adversos , Trasplante Homólogo/patologíaRESUMEN
In 1999, hospitals in Ontario, Canada, collaborated with a university-based research team to develop a report on the relative performance of individual hospitals in Canada's most populated province. The researchers used the balanced-scorecard framework advocated by Kaplan and Norton. Indicators of performance were developed in four areas: clinical utilization and outcomes, patient satisfaction, system integration and change, and financial performance and condition. The process of selecting, calculating, and validating meaningful indicators of financial performance and condition is outlined. Lessons learned along the way are provided. These lessons may prove valuable to other finance researchers and practitioners who are engaged in performance measurement endeavors.
Asunto(s)
Benchmarking , Auditoría Financiera , Administración Financiera de Hospitales/normas , Hospitales Comunitarios/economía , Indicadores de Calidad de la Atención de Salud , Eficiencia Organizacional , Hospitales Comunitarios/normas , Difusión de la Información , Ontario , Proyectos de Investigación , Responsabilidad Social , Sociedades HospitalariasRESUMEN
Developing mechanisms for making benchmark comparisons among hospital organization is a challenge that has been embraced by nurse executives. A methodologic approach for ensuring data congruency when using available secondary data bases for making benchmark comparisons was detailed in part one (July/August) of this two-part series. This second article analyzes nursing management data using a set of nursing and financial resource variables identified by senior nurse executives of the hospital sites involved in this study.
Asunto(s)
Bases de Datos como Asunto , Enfermeras Administradoras/organización & administración , Personal de Enfermería en Hospital/economía , Admisión y Programación de Personal/economía , Benchmarking , Atención a la Salud/organización & administración , Humanos , Pacientes Internos/clasificación , Asistentes de Enfermería/economía , Asistentes de Enfermería/provisión & distribución , Personal de Enfermería en Hospital/provisión & distribución , OntarioRESUMEN
Challenges associated with the use of secondary data sources for benchmarking in nursing administration research are identified. A methodological approach for ensuring data consistency is presented in part one of this two-part series. Part two (September 2000) will provide an analysis of the nursing management data, based on a set of nursing and financial resource benchmarking variables identified by the senior nurse executives of these sites. Initial findings show evidence of data consistency across similar hospitals.
Asunto(s)
Benchmarking/métodos , Recolección de Datos/normas , Interpretación Estadística de Datos , Bases de Datos Factuales/normas , Investigación en Administración de Enfermería/métodos , Investigación en Administración de Enfermería/normas , Proyectos de Investigación/normas , Indización y Redacción de Resúmenes/normas , Guías como Asunto , Recursos en Salud/clasificación , Recursos en Salud/estadística & datos numéricos , Hospitales Universitarios , Humanos , Personal de Enfermería en Hospital/economía , Personal de Enfermería en Hospital/provisión & distribución , Supervisión de Enfermería/organización & administración , Ocupaciones/clasificación , Ocupaciones/estadística & datos numéricos , Ontario , Admisión y Programación de Personal , Reproducibilidad de los Resultados , Salarios y BeneficiosRESUMEN
BACKGROUND: The functional consequences of vascular remodeling in rat aorta allografts were studied at different times after transplantation (Tx). METHODS: At days 1, 3, 7, 14, 28, and 56 after Tx, rat aorta allografts (Dark Agouti [DA]-to-Lewis) were mounted as isolated organs, and their contractile properties tested with phenylephrine, KCl, or endothelin-1. Controls were native DA-aortae and DA-syngeneic grafts. Changes in alpha smooth muscle actin and morphology were assessed by immunoblotting and histology. RESULTS: PostTx syngeneic grafts presented similar functional and morphological properties to native aortae. In allografts, no morphological changes was detected at day 7 after Tx, but phenylephrine-induced vasoconstriction was reduced by 60%. Signs of medial smooth muscle cell (SMC) loss and adventitial inflammation were observed at day 14 after Tx, without neointima formation. A complete loss of contractile property was observed at day 28 after Tx in association with a 75% decrease in alpha-SMC actin, severe adventitial inflammation, and reduced medial cellularity. At this time, neointima was restricted to both edges of allografts. At day 56 after Tx, allografts were also not functional and exhibited neointima on their entire length. All these changes were prevented by treating recipients with cyclosporine (7.5 mg/kg/day). CONCLUSION: These results indicate that, after Tx, the contractile property of rat aorta allografts is altered before manifest vascular remodeling. Because this can be prevented by cyclosporine, it most likely reflects an acute rejection of SMC. These results also show that vascular graft dysfunction can be used to monitor the development of rejection in the rat aorta allograft model.
Asunto(s)
Aorta Abdominal/fisiopatología , Aorta Abdominal/trasplante , Músculo Liso Vascular/patología , Músculo Liso Vascular/fisiopatología , Actinas/metabolismo , Animales , Aorta Abdominal/efectos de los fármacos , Aorta Abdominal/fisiología , Endotelina-1/farmacología , Terapia de Inmunosupresión , Técnicas In Vitro , Fenilefrina/farmacología , Periodo Posoperatorio , Potasio/farmacología , Ratas , Ratas Endogámicas Lew , Ratas Endogámicas , Trasplante Isogénico , Vasoconstrictores/farmacologíaRESUMEN
We reported previously that no classical features of hyperacute rejection (HAR) could be found in liver grafts in the guinea-pig (GP)-to-rat model and that recipients died shortly after transplantation of non-immunologic causes. Thus, the GP-to-rat model is not suitable for studying the mechanisms of discordant liver xenograft rejection. In the hamster to rat model, long-term survival of a liver graft is possible, but extremely low levels of xenoreactive natural antibodies are present. To mimic a discordant situation with pre-formed IgM and IgG antibodies, we sensitized rats 1 or 5 weeks before grafting. Specific anti-hamster IgM antibodies were found in recipients sensitized at week -1 but not week -5. Anti-hamster IgG was present in all recipients, albeit considerably higher in animals sensitized 5 weeks before grafting. In these two models, we examined the mechanism of HAR of liver grafts and compared this with heart xenografts. Control heart and liver grafts were rejected 4 and 7 days after transplantation respectively. Liver grafts in recipients sensitized at week -5 showed venous congestion and bleeding after reperfusion, indicating HAR, however this was not observed after sensitization at week -1. This surprising finding was confirmed by histology. Massive extravasation, edema, and acute liver cell degradation were noticed in grafts subjected to HAR. Liver grafts of recipients sensitized at week -1 showed only minimal changes. Heart grafts were rejected hyperacutely in both sensitization models. IgG antibodies could be detected on liver grafts in the group sensitized at week -5 but not in the group sensitized at week -1. Minimal IgM depositions were found on liver grafts of animals sensitized 1 week before grafting. Rejected heart grafts from similar sensitization groups showed identical antibody depositions; only IgM depositions were massive. Complement depositions were found in all groups. These results indicate that IgG, but not IgM, mediates HAR in hepatic xenografting. Such a predominance of IgG over IgM does not exist for heart grafts.
Asunto(s)
Rechazo de Injerto/inmunología , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Trasplante de Hígado , Inmunología del Trasplante , Animales , Anticuerpos Heterófilos/inmunología , Especificidad de Anticuerpos , Cricetinae , Femenino , Cobayas , Trasplante de Corazón , Mesocricetus , Ratas , Trasplante HeterólogoRESUMEN
Currently xenotransplantation is being discussed on national and international levels as a possible solution to tranplantation waiting lists, in view of the lack of alternative therapies. In recent years, enormous progress has been made in the area of immunology, especially concerning hyperacute rejection. However, long-term survival is still fiction due to relatively unknown, sequential rejection processes. Moreover, it remains questionable if xenogeneic organs will function physiologically, especially if they are metabolically complex. A third problem is the possible infectious risk of xenotransplantation to the patient and the population. Regarding this hazard, various committees and policy reports demand clarity first before the initial clinical transplantations become fact. In the Netherlands, the government largely adopted an identical advice by the Health Council. Artificial organs and cloning developments indicate that xenotransplantation might merely be an intermediate station in the route to develop adequate treatment for patients with organ failure.
Asunto(s)
Rechazo de Injerto/inmunología , Reacción Injerto-Huésped/inmunología , Trasplante Heterólogo/inmunología , Zoonosis/transmisión , Animales , Política de Salud , Humanos , Países Bajos , Trasplante Heterólogo/efectos adversos , Trasplante Heterólogo/normasRESUMEN
At the entrance of a new era, clinical xenotransplantation is a valued and auspicious option in tackling the problem of donor shortage. Because of ethical and anatomical issues, domestic farm animals are considered the most favourable species for organ donation, but transplantation of their organs leads to a complex process of rejection. Mechanistically, three immunological barriers, namely hyperacute rejection, delayed xenograft rejection and a subsequent cellular rejection, are distinguished. A fifth (microbiological) barrier is also being recognised. This review focuses on problems regarding the fourth barrier, i.e. physiology, in possible clinical settings and their corresponding animal models. Besides anatomical differences and posture, biochemical differences may have a severe impact on recipient survival. Differences in blood components and electrolyte and other biochemical concentrations are easily detected throughout the species considered for xenotransplantation. Enzymes and hormones have complex routes of action, activation and inhibition, and their molecular differences can impede function. As infusion or medicine may correct certain imbalances in electrolytes and proteins, problems with complex interactions might be difficult to retrieve and solve. Experimentally, survival of discordant xenografts show promising results, but the first physiological problems have already been detected. So, based upon the few experimental data available and the comparison of veterinary physiology, one might expect differences between the organs grafted, regarding the possible occurrence of physiological problems. Moreover, precautions must be taken to extrapolate long-term survival, because of species specificity.
Asunto(s)
Inmunología del Trasplante/inmunología , Trasplante Heterólogo/inmunología , Enfermedad Aguda , Animales , Rechazo de Injerto/inmunología , Supervivencia de Injerto/inmunología , Humanos , Inmunidad CelularRESUMEN
The objective of this study was to develop an animal model to evaluate the biology of hepatocellular carcinoma (HCC) recurrence after liver transplantation. HCC was induced in Brown Norway (BN) rats (n = 45) by diet-hylnitrosamine (DEN) administered continuously through the drinking water. Starting from day 14, rats were sequentially autopsied or syngeneically transplanted according to Kamada's cuff technique. After 74 days of DEN administration, neoplastic liver lesions appeared and after a mean of 102 days (SD +/- 6) the animals died of abdominal haemorrhage from liver tumours. At this time lung metastases were present in three-fifths animals. Transplantation success was dependent on the DEN consumption and thereby the tumour stadium. After 74 days of DEN administration BN rats could no longer be transplanted because of anaesthetic problems or technical problems due to tumour adhesion to surrounding tissues. No recurrence was found in the transplants. In conclusion, we believe that timing of the operation in this HCC model is essential because the physical condition of the animals prohibits orthotopic liver transplantation in an advanced tumour stage. With a different DEN dosage scheme this problem may be solved.
Asunto(s)
Carcinoma Hepatocelular/cirugía , Modelos Animales de Enfermedad , Neoplasias Hepáticas/cirugía , Trasplante de Hígado , Animales , Ratas , Ratas Endogámicas BNRESUMEN
A PVG rat with total deficiency of C6 and partial deficiency of C2 (PVG/c-), and a syngeneic control strain (PVG/c+), were used to study the production of extrahepatically synthesized complement. Livers of complement deficient rats were transplanted in sufficient rats (Tx-L). The C6 and C2 levels in Tx-L rats declined within 2 days to 25% and 30%, respectively, and remained stable for more than 6 weeks. To investigate the contribution of C6 synthesis by the liver, C6 sufficient livers were grafted in deficient rats (Tx + 1). After an initial increase, with maximum C6 levels of 119% at 10 days following transplantation, the C6 levels decreased gradually and C6 was no longer detectable 28 days after transplantation. This decline in C6 levels was dependent on antibody production against C6. No significant change in the C3, C4, factor H and factor B levels was observed. Expression of C6 mRNA in the grafted PVG/c+ sufficient liver was comparable to the expression of C6 mRNA in control PVG/c+ livers while C6 mRNA expression in the transplanted PVG/ c- liver and the control PVG/c- liver was lower. In conclusion, it was demonstrated in vivo that not only C6 but also C2 is synthesized extrahepatically in PVG/c rats.
Asunto(s)
Complemento C2/biosíntesis , Complemento C2/genética , Complemento C6/biosíntesis , Complemento C6/genética , Ratas Endogámicas/inmunología , Animales , Anticuerpos/sangre , Complemento C2/deficiencia , Complemento C6/deficiencia , Complemento C6/inmunología , Ensayo de Actividad Hemolítica de Complemento , Hígado/inmunología , Hígado/metabolismo , Trasplante de Hígado/inmunología , ARN Mensajero/biosíntesis , Ratas , Ratas Endogámicas/genética , Trasplante IsogénicoRESUMEN
In order to study the contribution of extrahepatic C6 to anti-Thy1.1 nephritis, C6 deficient PVG/c- livers were grafted in C6 sufficient PVG/c+ rats (Tx-L). Infusion of anti-Thy1.1 antibodies in Tx-L and PVG/c+ rats resulted in generation of C5b-9 complexes and subsequent glomerular injury, while infusion of anti-Thy1.1 antibodies in PVG/c- rats revealed no detectable C6 deposition. Because C6 mRNA was expressed in both liver and kidney tissue of PVG/c+ rats, we assessed whether production of C6 in the kidney alone was sufficient for glomerular injury. One kidney of a PVG/c- rat was replaced with a PVG/c+ kidney (Tx + K) followed by administration of anti-Thy1.1 antibodies. C6 deposits were detectable neither in PVG/c+ kidneys nor in PVG/c- kidneys of Tx + K rats, indicating that C6 production in PVG/c+ kidneys alone is not sufficient to contribute to renal injury. That C6 production had occurred was suggested by the presence of equal amounts C6 mRNA in control PVG/c+ kidneys and in grafted PVG/c+ kidneys of Tx + K rats. C6 mRNA expression in kidney tissue of PVG/c+ rats is presumably derived from peritubular sites. In conclusion, we have demonstrated that extrahepatic, but not renal synthesis of, C6 is sufficient to contribute to glomerular injury during anti-Thy1.1 nephritis.
Asunto(s)
Complemento C6/metabolismo , Complejo de Ataque a Membrana del Sistema Complemento/metabolismo , Riñón/metabolismo , Hígado/metabolismo , Animales , Biomarcadores , Complemento C2/deficiencia , Complemento C6/deficiencia , Complemento C6/genética , Técnica del Anticuerpo Fluorescente , Trasplante de Riñón , Trasplante de Hígado , Nefritis/inmunología , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas/sangre , Ovinos/sangre , Antígenos Thy-1/inmunologíaAsunto(s)
Rechazo de Injerto/inmunología , Supervivencia de Injerto/inmunología , Trasplante de Corazón/inmunología , Trasplante Heterólogo/inmunología , Animales , Proteínas Inactivadoras de Complemento , Dexametasona/farmacología , Venenos Elapídicos/farmacología , Rechazo de Injerto/patología , Supervivencia de Injerto/efectos de los fármacos , Cobayas , Trasplante de Corazón/patología , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/inmunología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Ratas , Ratas Endogámicas Lew , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Trasplante Heterólogo/patologíaRESUMEN
Several groups have demonstrated that it is possible to obtain long-term graft survival of concordant xenografts. One of the important questions that remains is whether xenografts are susceptible to chronic rejection. To answer this question we used the aorta transplantation model. One centimetre of hamster aorta was interposed in the abdominal aorta of Lewis rat recipients. The recipients were either untreated (group 1), or treated with 10 mg/kg cyclosporine (CsA), given intramuscularly three times a week (group 2). Rats were sacrificed at day 7, 14, 21, 28, 56 and 84 and the thickness of the intima, the media and the adventitia was measured. Furthermore, the cellularity of the media and the adventitia was assessed by counting the number of nuclei per 0.05 mm2 and immunohistochemistry of the aortic grafts was performed. Graft arteriosclerosis developed in aortic xenografts of both group 1 and group 2. In group 1, intimal lesions were already present from day 21 onwards in all rats, whereas in group 2 they were present only in 33% (2/6) of the rats. At day 84 all the grafts in group 1 were totally occluded, while those in group 2 were still open. The thickness of the media was slightly increased in both groups during the whole observation period, mainly due to edema. Although a few infiltrating macrophages could be seen, the number of nuclei per 0.05 mm2 of the media remained constant during the first 21 days, but declined sharply from day 21 onwards, as a consequence of disappearing myocytes. Thickness of the adventitia in both groups increased after transplantation due to infiltrating macrophages and T cells, reaching a peak at day 14. After day 14 the adventitial thickness in group 1 decreased rapidly to reach values comparable to group 2 from day 28 onwards. In conclusion, graft arteriosclerosis, as a sign of chronic rejection, occurs in concordant aortic xenografts. The lesions in the xenografts develop extremely rapidly, and compared to data from the literature, faster than in aortic allografts. The process of chronic rejection in aortic xenografts can be reduced by CsA.
Asunto(s)
Aorta Torácica/trasplante , Trasplante Heterólogo , Trasplante Heterotópico , Animales , Anticuerpos/análisis , Aorta Abdominal , Arteriosclerosis/etiología , Relación CD4-CD8 , Cricetinae , Rechazo de Injerto/etiología , Pruebas de Hemaglutinación , Inmunohistoquímica , Macrófagos/citología , Masculino , Mesocricetus , Ratas , Ratas Endogámicas Lew , Trasplante Heterólogo/inmunología , Trasplante Heterotópico/efectos adversosAsunto(s)
Antígenos CD/biosíntesis , Trasplante de Corazón/inmunología , Glicoproteínas de Membrana/biosíntesis , Trasplante Heterólogo/inmunología , Animales , Antígenos CD/análisis , Antígenos CD55/biosíntesis , Proteínas Inactivadoras de Complemento/biosíntesis , Femenino , Trasplante de Corazón/fisiología , Humanos , Riñón/inmunología , Hígado/inmunología , Proteína Cofactora de Membrana , Glicoproteínas de Membrana/análisis , Ratones , Ratones Transgénicos , Miocardio/inmunología , Especificidad de Órganos , Ratas , Bazo/inmunología , Trasplante HeterotópicoAsunto(s)
Trasplante de Corazón , Trasplante de Hígado , Trasplante Heterólogo , Animales , Anticuerpos Heterófilos/biosíntesis , Proteínas Inactivadoras de Complemento/uso terapéutico , Cricetinae , Venenos Elapídicos/uso terapéutico , Estudios de Factibilidad , Femenino , Cobayas , Trasplante de Corazón/inmunología , Trasplante de Corazón/patología , Trasplante de Hígado/inmunología , Trasplante de Hígado/patología , Mesocricetus , Esplenectomía , Trasplante Heterólogo/inmunología , Trasplante Heterólogo/patologíaAsunto(s)
Venenos Elapídicos/administración & dosificación , Trasplante de Corazón/inmunología , Animales , Activación de Complemento/efectos de los fármacos , Proteínas Inactivadoras de Complemento/farmacología , Ciclosporina/administración & dosificación , Femenino , Rechazo de Injerto/inmunología , Supervivencia de Injerto , Guanidinas/farmacología , Cobayas , Trasplante de Corazón/patología , Inmunosupresores/administración & dosificación , Masculino , Ratas , Ratas Endogámicas Lew , Esplenectomía , Linfocitos T/inmunología , Trasplante HeterólogoAsunto(s)
Anticuerpos Heterófilos/inmunología , Proteínas del Sistema Complemento/inmunología , Supervivencia de Injerto/inmunología , Trasplante de Corazón/inmunología , Terapia de Inmunosupresión/métodos , Trasplante Heterólogo/inmunología , Animales , Proteínas Inactivadoras de Complemento/farmacología , Venenos Elapídicos/farmacología , Cobayas , Masculino , Ratas , Ratas Endogámicas Lew , Esplenectomía , Factores de Tiempo , Trasplante Heterotópico , Irradiación Corporal TotalAsunto(s)
Aorta Torácica/trasplante , Rechazo de Injerto/inmunología , Trasplante Heterólogo/inmunología , Animales , Aorta Torácica/patología , Cricetinae , Ciclosporina/uso terapéutico , Rechazo de Injerto/patología , Masculino , Mesocricetus , Músculo Liso Vascular/patología , Músculo Liso Vascular/trasplante , Ratas , Ratas Endogámicas Lew , Factores de Tiempo , Trasplante Heterólogo/patologíaRESUMEN
In a recently developed guinea pig model of allergic asthma, we investigated the relationships between allergen-induced bronchial hyperreactivity in vivo, tracheal smooth muscle function in vitro, and the number of inflammatory cells in the bronchoalveolar lavage. At 6 h after allergen provocation (after the early asthmatic reaction) bronchial hyperreactivity to histamine aerosol was observed, which was still present, but reduced, at 24 h after the challenge (after the late asthmatic reaction). The severity of bronchial hyperreactivity at 6 h and at 24 h after each of four daily allergen provocations was progressively reduced. The contractile properties of tracheal smooth muscle preparations in response to methacholine or histamine were not changed at 6 h and 24 h after a single allergen provocation, as well as at 24 h after the fourth of the repeated provocations. However, the sensitivity to isoprenaline-induced relaxation of a half-maximal contraction obtained with methacholine or histamine was significantly reduced at 24 h after either a single or the fourth of the repeated provocations. The time course of the reduced beta-adrenoceptor sensitivity in vitro did not correlate with that of bronchial hyperreactivity in vivo. However, it was parallelled by a progressive infiltration of inflammatory cells in the airways, suggesting that mediators from these cells may decrease airway smooth muscle beta-adrenoceptor sensitivity.